| Study With Phage for CF Subjects With Pseudomonas Lung Infection (NCT06998043) | BiomX Ltd | 2025-07-02 |
| A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases (NCT06947694) | Xinqiao Hospital of Chongqing | 2025-07-02 |
| A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis (NCT06649695) | European Myeloma Network B.V. | 2025-07-02 |
| A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD (NCT06981078) | Upstream Bio Inc. | 2025-07-02 |
| A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma (NCT07312188) | Shandong New Time Pharmaceutical Co., LTD | 2025-07-02 |
| A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) (NCT07063212) | Memorial Sloan Kettering Cancer Center | 2025-07-02 |
| Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma (NCT06940518) | M.D. Anderson Cancer Center | 2025-07-02 |
| Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSD (NCT06608277) | Northwestern University | 2025-07-02 |
| A Long-term Study of HSK44459 Tablets in Participants With Bechet's Disease (NCT07070739) | Haisco Pharmaceutical Group Co., Ltd. | 2025-07-01 |
| Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis (NCT05408910) | Wake Forest University Health Sciences | 2025-07-01 |
| Use of Progenitor Biological Bandages in Burn Care (Bru_PBB) (NCT05339490) | Dr Anthony De Buys Roessingh | 2025-07-01 |
| Ginger Root Extract for Sciatic Pain Individuals (NCT06817018) | Leslie Shen | 2025-07-01 |
| Brimonidine Eye Drops in the Prevention of Myopia Progression (NCT06996236) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2025-07-01 |
| Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial) (NCT07073365) | Pusan National University Hospital | 2025-07-01 |
| Hyaluronic Acid in the Treatment of Hyposalivation (NCT07309588) | Poznan University of Medical Sciences | 2025-07-01 |
| Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes (NCT07047183) | Yehui Tan | 2025-07-01 |
| Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis (NCT07055724) | Nanjing IASO Biotechnology Co., Ltd. | 2025-07-01 |
| A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases (NCT05620914) | Mustafa Khasraw, MBChB, MD, FRCP, FRACP | 2025-07-01 |
| Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors (NCT07058948) | Tianjin Medical University Cancer Institute and Hospital | 2025-07-01 |
| Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration (NCT05999383) | University of California, San Francisco | 2025-07-01 |
| Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer (NCT05690035) | Sun Yat-sen University | 2025-07-01 |
| A Study on Immunotherapy Combined With Radiotherapy for Esophagogastric Junction/Gastric Adenocarcinoma (NCT07053332) | Jiangsu Cancer Institute & Hospital | 2025-07-01 |
| Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC (NCT07047755) | Henan Cancer Hospital | 2025-07-01 |
| Efficacy of Microneedling With Vitamin C in Performing Gingival Depigmentation (NCT07070024) | Fayoum University | 2025-07-01 |
| Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options? (NCT07069933) | Mansoura University | 2025-07-01 |
| Extracorporeal Photopheresis in Early Diffuse Cutaneous Systemic Sclerosis (NCT04986605) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2025-07-01 |
| PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer (NCT07472140) | N.N. Alexandrov National Cancer Centre | 2025-07-01 |
| A Study of QLS5133 Monotherapy in Advanced Solid Tumors (NCT07061639) | Qilu Pharmaceutical Co., Ltd. | 2025-07-01 |
| Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery (NCT01422148) | Baystate Medical Center | 2025-07-01 |
| Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma (NCT07030140) | Jinbo Yue | 2025-07-01 |
| Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC (NCT06998719) | Bi Nan | 2025-07-01 |
| Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease (NCT06986382) | Stanford University | 2025-07-01 |
| The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC (NCT06965829) | Shanghai Chest Hospital | 2025-07-01 |
| Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer (NCT06973421) | Fudan University | 2025-07-01 |
| Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor (NCT06311955) | Jian Chen | 2025-07-01 |
| Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I) (NCT07057089) | Hebei Medical University Fourth Hospital | 2025-07-01 |
| Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents (NCT07168980) | Children's Cancer Group, China | 2025-07-01 |
| Topical Cannabidiol for Treating Carpal Tunnel Syndrome (NCT06108349) | University of Virginia | 2025-07-01 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of BEY2153 in Patients with Early Alzheimer's Disease (NCT06885567) | BeyondBio Inc. | 2025-07-01 |
| Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy (NCT07022301) | First Affiliated Hospital of Wannan Medical College | 2025-07-01 |
| Investigating Pre-Procedural Anxiety and Effect of Analgesia on Intrauterine Device Placement and Endometrial Biopsy (NCT07031206) | The University of Texas Health Science Center, Houston | 2025-07-01 |
| Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease (NCT06053164) | University of Alberta | 2025-07-01 |
| Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment (NCT07199296) | Ruijin Hospital | 2025-07-01 |
| Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome (NCT06953466) | Quoin Pharmaceuticals | 2025-07-01 |
| Treatment Planning for ABA Employing Auxiliary Tools V2+ (TREAAT2+) (NCT06204536) | Montera Health Texas LLC | 2025-07-01 |
| A Study of AMC6156 in People With Sarcopenia (NCT07072195) | Animuscure Inc. | 2025-07-01 |
| Dexmedetomidine Versus Morphine During Cooling Therapy in Neonates (NCT06985290) | Ipsita Goswami | 2025-07-01 |
| a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer . (NCT07035808) | Zhejiang Cancer Hospital | 2025-07-01 |
| Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer (NCT07090031) | Qingdao Central Hospital | 2025-07-01 |
| PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer (NCT07472153) | N.N. Alexandrov National Cancer Centre | 2025-07-01 |
| A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets (NCT06972498) | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | 2025-07-01 |
| Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions (NCT07090525) | Qingdao Central Hospital | 2025-07-01 |
| MRG-001 in Patients With Amyotrophic Lateral Sclerosis (NCT06315608) | MedRegen LLC | 2025-07-01 |
| A Phase 2 Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis (NCT06725017) | Guangzhou Zhiyi Biotechnology Co., Ltd. | 2025-07-01 |
| TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation (NCT07287800) | University of California, Los Angeles | 2025-07-01 |
| Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients (NCT06999252) | Fudan University | 2025-07-01 |
| Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (NCT06989333) | Jiuwu Bai | 2025-07-01 |
| 68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses (NCT07101900) | Peking Union Medical College Hospital | 2025-07-01 |
| Evaluation of the Efficacy and Safety of Adebrelimab Combined With SOX as Adjuvant Therapy for IIIB and IIIC Gastric Cancer (NCT07033143) | Tianjin Medical University Cancer Institute and Hospital | 2025-07-01 |
| Evaluating the Efficacy and Safety of Metformin in Vitiligo (NCT05607316) | University of Massachusetts, Worcester | 2025-07-01 |
| Evaluate the Precision of ABL-101 Perfluorocarbon and Fluorine-19 MRI for the Mapping of Atherosclerotic Plaque Composition and Inflammation in Patients Undergoing Carotid Endarterectomy (NCT06850324) | Ruud van Heeswijk | 2025-07-01 |
| Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients (NCT07056439) | Jiangsu HengRui Medicine Co., Ltd. | 2025-07-01 |
| A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm (NCT06940804) | BioNTech SE | 2025-07-01 |
| An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations (NCT07037238) | Xuanwu Hospital, Beijing | 2025-07-01 |
| Effect of Amitriptyline and Trifluoperazine on Patients With Functional Dyspepsia (NCT07008235) | Md. Moktadirul Hoque Shuvo | 2025-07-01 |
| Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial) (NCT06972758) | Yonsei University | 2025-07-01 |
| Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma (NCT07079410) | Shanghai Zhongshan Hospital | 2025-07-01 |
| Psilocybin Therapy for Psychological Distress in Palliative Patients (NCT06782724) | University Medical Center Groningen | 2025-07-01 |
| Optimal Application Timing of ADC Drugs for Advanced Breast Cancer (NCT07657130) | Liaoning Cancer Hospital & Institute | 2025-07-01 |
| Pilot fMRI Studies of Aging-Related Effects of THC (NCT06647524) | Yale University | 2025-07-01 |
| Surgery for Relapsed Ovarian Cancer in Precision (NCT06602063) | Shanghai Gynecologic Oncology Group | 2025-07-01 |
| A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) (NCT06937749) | Innovent Biologics (Suzhou) Co. Ltd. | 2025-07-01 |
| Neoadjuvant Tislelizumab, Gemcitabine, Cisplatin and S-1 for Resectable High-risk Cholangiocarcinoma (NCT06903273) | National Cheng-Kung University Hospital | 2025-07-01 |
| Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis) (NCT06939816) | Enyo Pharma | 2025-07-01 |
| A Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC (NCT07038460) | Wen-zhao ZHONG | 2025-07-01 |
| Micro-Needling Technique Using Ozonated Olive Oil in Periodontal Diseases (NCT06990282) | Fayoum University | 2025-07-01 |
| Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma (NCT07188103) | Anhui Provincial Hospital | 2025-07-01 |
| Safety and Preliminary Efficacy of TrophiPatch, an Adipose-Derived Stromal Cell Patch for Chronic Leg Ulcers (NCT07048054) | Nicolò Brembilla | 2025-07-01 |
| Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC (NCT06861894) | Zhigang Li | 2025-07-01 |
| Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP (NCT07057778) | Peking University People's Hospital | 2025-07-01 |
| Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy (NCT07067307) | Mansoura University | 2025-07-01 |
| Sintilimab Plus Apatinib and SOX as First-line Treatment in Patients With AFP Gastric or Gastroesophageal Junction Adenocarcinoma (NCT06973330) | Anhui Provincial Cancer Hospital | 2025-07-01 |
| 0.005% Latanoprost Gel for Nonsegmental Vitiligo (NCT07016113) | Universitas Padjadjaran | 2025-07-01 |
| MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents (NCT06353282) | University of California, Los Angeles | 2025-07-01 |
| Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls (NCT06808516) | University Hospital, Basel, Switzerland | 2025-07-01 |
| A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL (NCT07031700) | Tianjin Medical University Cancer Institute and Hospital | 2025-07-01 |
| Treatment of Periodontitis by Tulsi Gel (NCT06675578) | Al-Azhar University | 2025-07-01 |
| Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy (NCT07022743) | Obafemi Awolowo University | 2025-07-01 |
| Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) (NCT06939036) | Ariceum Therapeutics GmbH | 2025-07-01 |
| A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B (NCT07203118) | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | 2025-07-01 |
| Study of S1B-408 in Women With Orgasmic Dysfunction (NCT06516055) | S1 Biopharma, Inc. | 2025-07-01 |
| Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases (NCT06828042) | Peking University Third Hospital | 2025-07-01 |
| BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma (NCT07008053) | Tianjin Medical University Cancer Institute and Hospital | 2025-07-01 |
| Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia (NCT07007936) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2025-07-01 |
| An Explorative Study of HRS-2189 Combined With Adebrelimab and BP102 for Metastatic Colorectal Cancer (NCT07061210) | Fudan University | 2025-07-01 |
| Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells (NCT03535246) | Shenzhen Geno-Immune Medical Institute | 2025-07-01 |
| Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer (NCT06047015) | University of Saskatchewan | 2025-07-01 |
| The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial (NCT07212933) | Chinese PLA General Hospital | 2025-07-01 |
| Immunotherapy Treating GI Cancer (NCT03614650) | Shenzhen Geno-Immune Medical Institute | 2025-07-01 |
| Feasibility and Safety of Targeting Neutral vs Liberal Fluid Balance in Traumatic Brain Injured Patients- LIMIT-TBI Trial (NCT07625995) | Erasme University Hospital | 2025-07-01 |